Materialise - From Bench to Bedside - Brochure

3D Planning from Bench to Bedside

Cardiovascular patient analysis and planning by Materialise

The recipe for success

Achieve your goal of helping patients by bringing life-changing technology to market.

Be competitive Gain market share and stay ahead with innovative solutions for clinicians and patients Be efficient Realize cost benefit as a result of robust and scalable processes to reach and help more patients

Trends that dictate the pace The race to market Successfully bring a new generation of C&V devices to market as rapidly as possible to bring transformative solutions for clinicians and patients. In being the first, you’ll capture the largest market share and maximize the impact of your technology on cardiovascular healthcare. Your research will impact patient lives and you’ll gain return on your investments. Fast design adaptations and optimal patient inclusion rates are essential to assure efficiency in R&D and clinical trials. This efficiency combined with good clinical outcomes will help increase your chances in winning the race.

Personalized guidance to navigate complex treatments

Society is becoming more demanding as technology has evolved to enable tailored experiences in all aspects of life. Clinicians are no exception — they need clear and efficient communication tools for planning at their fingertips. They want a highly personalized service that gives them critical information where and when they need it. With an intuitive service that bypasses tedious processes, clinicians won’t need to look further.

Face the challenges Overcome your challenges and successfully bring transformative solutions to clinicians and patients. Current innovation in 3D planning and online planning communication can give you a competitive edge and expand your reach in helping more patients. With the latest tools in hand, your new process efficiencies will assist you in the race to the market.

The power of 3D planning

Bring clarity to complexity by using 3D CT planning. Deliver 3D printing definition to the virtual world and efficiently handle increasing number of cases without compromising your insights.

Gain market share and be the first on the market Create evidence with reliable tools for post-op analysis Ensure favorable clinical outcomes through planning

Optimize patient selection

Optimally prepare physicians for procedures Provide a clear road map for a successful intervention

Measure accurately and gain better insights on anatomy Contribute to treating more patients and accelerating clinical trials

Boost their confidence

The power of online planning

Communicate clearly with clinicians and your colleagues by digitizing and personalizing the service provided. Deliver added value that clinicians didn’t even know they needed while cementing their loyalty with ease of use.

Facilitate communication Involve all stakeholders easily Anywhere, anytime

Gain efficiency Save time by avoiding tedious processes Manage your cases while scaling up

FROM BENCH...

...TO BEDSIDE

R&D

CLINICAL TRIALS

AFTER MARKET CLEARANCE

3D every step of the way Benefit from using 3D throughout the product life cycle.

in R&D​

in clinical trials​

after market clearance

Correctly quantify your target population and validate your prototype in a realistic test set-up. Learn more >

Maximize your success with accurate patient screening and planning, based on true 3D.

Scale up the number of patients while remaining consistent and efficient.

Learn more >

Learn more >

After market clearance challenges

Once your product is commercially available, there are still challenges remaining to stay competitive and efficient.

Making it intuitive for physicians to adopt your novel structural heart device​ Handling increasing patient numbers in a consistent and time-efficient way​ Facilitating effective communication and case management​ Collecting evidence and prioritizing good outcomes for patients

How Materialise can support after market clearance

“Cat-scan imaging of the chest, in conjunction with Mimics, helped to determine whether the SynCardia Total Artificial Heart could actually be placed in the child’s chest.”

Innovative solutions can support you in extending a personalized experience to clinicians.

Delivering detailed 3D insights on how the implanted device and the patient’s anatomy would interact Automating your 3D planning workflow to reduce time and inter-user variability Providing an online case review and communication platform

-D. Bradford Sanders, chief perfusionist at Phoenix Children’s Hospital

Offering reliable tools for 3D post-op analysis​

Clinical trial challenges

Once your product reaches the trial phase, innovative advantages will help power you through the race to market:

Selecting the most suitable patients while balancing the avoidance of cases with assured poor outcomes and cases where a suitable patient is excluded Ensure there are no surprises in the CATHLab and that the physicians are well trained and prepared​ Obtaining favourable clinical outcomes while ensuring >Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21

Made with FlippingBook Ebook Creator